| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
| 01/01/2009 | US20090005849 Methods and apparatuses for coating a lesion |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005558 (2-{7-[3-(4-cyanophenoxy)propyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl) carbamic acid tert-butyl ester; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/01/2009 | US20090005440 Pharmaceutical composition and health food comprising extract of phellinus sp.pl 3 or phellinsin a isolated from the same as an effective component for prevention and treatment of cardiovascular disease |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005434 Novel Salicylic Anilides |
| 01/01/2009 | US20090005429 Process for the preparation of carvedilol and its enantiomers |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005420 Inhibitors of Matrix Metallaproteinases |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005401 Novel Compounds |
| 01/01/2009 | US20090005395 Sildenafil n-oxide as prodrug |
| 01/01/2009 | US20090005394 Endothelin receptor antagonists |
| 01/01/2009 | US20090005392 Crystal of 6-[4-(4-pyridylamino) phenyl]-4,5-dihydro-3(2h-pyridazinone hydrochloride trihydrate |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005381 Methods of treating serotonin-mediated diseases and disorders |
| 01/01/2009 | US20090005377 Pyrazolopyridine Derivates |
| 01/01/2009 | US20090005375 Acetyl coenzyme a carboxylase inhibitors |
| 01/01/2009 | US20090005373 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/01/2009 | US20090005361 Combination of Organic Compounds |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005342 Composition Having Blood Pressure Reducing and/or Elevation Suppressing Effect and Food and Drink Containing the Same |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression |
| 01/01/2009 | US20090005327 Essential n-3 fatty acids in cardiac in sufficiency and heart failure therapy |
| 01/01/2009 | US20090005315 Vip Fragments and Methods of Use |
| 01/01/2009 | US20090005309 Substituted piperidines |
| 01/01/2009 | US20090004281 Multiparticulate osmotic delivery system |
| 01/01/2009 | US20090004260 Medicament comprising hgf gene |
| 01/01/2009 | US20090004243 Biodegradable triblock copolymers for implantable devices |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004187 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment (ridker) |
| 01/01/2009 | US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement |
| 01/01/2009 | US20090004177 Combination Treatment with t-PA Variant and Low Molecular Weight Heparin |
| 01/01/2009 | US20090004176 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004155 Method for treating a mammal having damaged myocardium tissue |
| 01/01/2009 | US20090004121 Combination of picotamide with nafronyl |
| 12/31/2008 | WO2009003061A1 Methods and compositions regarding polychalcogenide compositions |
| 12/31/2008 | WO2009002964A1 Methods of treating serotonin-mediated diseases and disorders |
| 12/31/2008 | WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/31/2008 | WO2009002746A1 Dosing schedules of leukotriene synthesis inhibitors for human therapy |
| 12/31/2008 | WO2009002203A1 Polyfunctional fullerene c60 aminoacid derivatives |
| 12/31/2008 | WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists |
| 12/31/2008 | WO2009001949A1 Pyrazolone derivative |
| 12/31/2008 | WO2009001928A1 Peptide having hypotensive activity |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001032A1 Modulation of inflammation |
| 12/31/2008 | WO2009000909A2 Salts of perindopril |
| 12/31/2008 | WO2009000907A2 Combination of picotamide with nafronyl |
| 12/31/2008 | WO2009000843A2 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist |
| 12/31/2008 | WO2009000811A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| 12/31/2008 | WO2009000592A1 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2008132568A3 Fusion proteins binding to growth factors |
| 12/31/2008 | WO2008129288A3 Disulfonamides useful in the treatment of inflammation |
| 12/31/2008 | WO2008121877A3 Cftr inhibitor compounds and uses thereof |
| 12/31/2008 | WO2008117241A3 Thiazolidine derivatives as orexin receptor antagonists |
| 12/31/2008 | EP2009109A1 G protein-related kinase mutants in essential hypertension |
| 12/31/2008 | EP2009011A1 Nitrogen-containing heterocyclic compound |
| 12/31/2008 | EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2008657A2 Use of rapamycin derivatives in vasculopathies |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2007725A2 Non-peptidic renin inhibitors nitroderivatives |
| 12/31/2008 | EP2007416A2 Remedies for ischemia |
| 12/31/2008 | EP2007404A2 Methods and systems for treating injured cardiac tissue |
| 12/31/2008 | EP2007403A2 Methods and systems for treating injured cardiac tissue |
| 12/31/2008 | EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 12/31/2008 | EP2007227A2 Lycopene for the treatment of metabolic dysfunction |
| 12/31/2008 | EP1869165A4 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 12/31/2008 | EP1494685B1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker |
| 12/31/2008 | EP1437137B1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 12/31/2008 | EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 12/31/2008 | EP1406867B1 Thiolalkyl benzoic acid derivatives |
| 12/31/2008 | EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 12/31/2008 | EP1322220A4 Methods for analyzing and using data from hypertensive patients |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP1218001B1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 12/31/2008 | CN101336251A Neuregulin variants and methods of screening and using thereof |
| 12/31/2008 | CN101336229A 改性的拟赖氨酸化合物 Proposed modification of lysine compound |
| 12/31/2008 | CN101333531A CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
| 12/31/2008 | CN101333500A Red rice products and applications thereof for preparing hypotensor |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333251A Artificial zinc finger protein transcription factor capable of starting A20 gene expression and use |
| 12/31/2008 | CN101333241A Process for extracting dioscin, preparation thereof and use |
| 12/31/2008 | CN101333216A Novel saltforming process of eprosartan mesylate |